Victor S. Goldmacher, Iosif Gershteyn, Ravi Chari, Yelena Kovtun. "A bispecific anti-MUC16/anti-death receptor 5 antibody achieves effective and tumor-selective death receptor 5-mediated tumor regression." Scientific Reports, 2025. doi:10.1038/s41598-025-93927-0